News

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...
Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...